The infectious etiology of chronic rheumatic diseases.

Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora. Infect Immun (1990) 1.02

Retroviruses and autoimmune rheumatic diseases. Clin Exp Immunol (1994) 0.89

Mycoplasmas and arthritis. Ann Rheum Dis (1992) 0.83

Clinically silent infections in patients with oligoarthritis: results of a prospective study. Ann Rheum Dis (1992) 0.81

Seroprevalence of Acanthamoeba Antibodies in Rheumatoid Arthritis Patients by IFAT, Tehran, Iran 2007. Iran J Parasitol (2010) 0.78

Rheumatology. Postgrad Med J (1991) 0.75

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med (1991) 7.01

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature (1994) 5.68

The molecular basis of antibody formation: a paradox. Proc Natl Acad Sci U S A (1965) 4.68

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61

Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 3.80

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest (1999) 2.48

United we stand. Ann Intern Med (1993) 2.16

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med (1999) 1.96

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88

Substrate-specific binding of hook-associated proteins by FlgN and FliT, putative chaperones for flagellum assembly. Mol Microbiol (1999) 1.86

A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83

The infectious etiology of rheumatoid arthritis. New considerations. Arthritis Rheum (1978) 1.69

Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood (1993) 1.68

Bacterial leaching patterns on pyrite crystal surfaces. J Bacteriol (1978) 1.58

Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci U S A (1993) 1.54

Asymptomatic blood donor with a false positive HTLV-III Western blot. N Engl J Med (1986) 1.54

HIV-specific cellular and humoral immune responses in primary HIV infection. AIDS Res Hum Retroviruses (1996) 1.51

Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS (1993) 1.48

High-sensitivity sequence determination of proteins quantitatively recovered from sodium dodecyl sulfate gels using an improved electrodialysis procedure. Anal Biochem (1980) 1.46

Amino-terminal amino acid sequence of the major structural polypeptides of avian retroviruses: sequence homology between reticuloendotheliosis virus p30 and p30s of mammalian retroviruses. Proc Natl Acad Sci U S A (1978) 1.46

Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A (1996) 1.44

Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses (1995) 1.42

Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav (2013) 1.41

Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer. Am J Med (1991) 1.41

Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis (1994) 1.40

Predictors of optimal virological response to potent antiretroviral therapy. AIDS (1999) 1.40

Fostering a new relationship between departments of medicine and teaching hospitals. Acad Med (1993) 1.39

Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects. Clin Pharmacol Ther (1995) 1.34

Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis (1999) 1.32

Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy. AIDS Res Hum Retroviruses (2006) 1.26

The transition from standard edgewise to preadjusted appliance systems. J Clin Orthod (1989) 1.20

Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report. Ann Intern Med (2000) 1.20

Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J Infect Dis (1998) 1.20

Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann Neurol (2000) 1.20

Alignment of the peptides derived from acid-catalyzed cleavage of an aspartylprolyl bond in the major internal structural polypeptide of avian retroviruses. J Biol Chem (1980) 1.17

Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14

Controlled space closure with a preadjusted appliance system. J Clin Orthod (1990) 1.13

High-sensitivity sequence analysis of proteins recovered from sodium dodecyl sulfate gels. Methods Enzymol (1983) 1.12

Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults. Antimicrob Agents Chemother (2000) 1.12

Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases. Clin Infect Dis (2001) 1.11

Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res (2000) 1.09

Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS Care (2002) 1.06

Isolation of F(c)5mu and Fabmu fragments of human IgM. Eur J Immunol (1973) 1.05

Amino-terminal amino acid sequence of p10, the fifth major gag polypeptide of avian sarcoma and leukemia viruses. J Virol (1983) 1.04

Bracket placement with the preadjusted appliance. J Clin Orthod (1995) 1.04

Measuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9). AIDS Care (2010) 1.04

C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM. J Exp Med (1975) 1.03

The structural basis for binding of complement by immunoglobulin M. J Exp Med (1974) 1.03

Gastrointestinal complications of HIV infection: changing priorities in the HAART era. Gut (2008) 1.03

Q fever endocarditis. Am J Med Sci (1986) 1.02

Anchorage control during leveling and aligning with a preadjusted appliance system. J Clin Orthod (1991) 1.02

Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil elastase from normal donors. Anal Biochem (1985) 1.02

The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Qual Life Res (1997) 1.01

Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products. J Virol (1979) 1.01

Tetrameric immune macroglobulins in three orders of bony fishes. Proc Natl Acad Sci U S A (1971) 1.00

The amino-terminal sequence of the heavy chain of human immunoglobulin M. Biochemistry (1968) 1.00

HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses (1994) 1.00

Antibodies to ribosomal ribonucleic acid (rRNA) in patients with systemic lupus erythematosus (SLE). Immunology (1970) 0.98

Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy. J Infect Dis (1999) 0.98

Issues in combination antiretroviral therapy: a review. J Acquir Immune Defic Syndr (1994) 0.98

Amino acid sequence of human D of the alternative complement pathway. Biochemistry (1984) 0.96

Antibodies to human native and denatured collagens in synovial fluids of patients with rheumatoid arthritis. Clin Immunol Immunopathol (1976) 0.93

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.92

Selective dansylation of M protein within intact influenza virions. J Virol (1982) 0.91

Use of fluorescamine as an effective blocking reagent to reduce the background in protein sequence analyses by the Beckman automated sequencer. Anal Biochem (1981) 0.90

The carbohydrate composition of immunoglobulins G. Biochim Biophys Acta (1971) 0.89

Purification and characterization of the gag gene products of avian-type C retroviruses by high-pressure liquid chromatography. Anal Biochem (1981) 0.89

Secondary structure of the immunoglobulin J chain. Proc Natl Acad Sci U S A (1985) 0.89

Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS. Immunopharmacology (1998) 0.88

Primary structure of human J chain: alignment of peptides from chemical and enzymatic hydrolyses. Biochemistry (1977) 0.88

Arthritis in systemic nocardiosis. South Med J (1982) 0.88

Partial amino acid sequence of human factor D:homology with serine proteases. Proc Natl Acad Sci U S A (1980) 0.86

Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol (1993) 0.86

Individuals infected with HIV possess antibodies against IL-2. Immunology (1988) 0.85

The protein nature of the Thy-1.2 alloantigen as expressed by the murin lymphoblastoid line S-49.1 TB-2-3. J Immunol (1975) 0.85

Physical and chemical characterization of an oyster hemagglutinin. J Biol Chem (1969) 0.85

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection. J Infect Dis (2000) 0.85

Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals. AIDS Res Hum Retroviruses (1999) 0.85

Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine. Adv Exp Med Biol (1996) 0.85

Purification and characterization of two classes of immunoglobulins from the marine toad, Bufo marinus. Biochemistry (1972) 0.85

Use of HIV viral load in clinical practice: back to the future. Ann Intern Med (1997) 0.84

Subfragments of the papain solubilized TL antigen. J Immunol (1975) 0.84

Isolation and characterization of the immune macroglobulin from the paddlefish, Polyodon spathula. J Biol Chem (1971) 0.83

Degradation of human IgM by pepsin: characterization of a high molecular weight fragment. J Immunol (1971) 0.83

Toward a definition of HIV expertise: a survey of experienced HIV physicians. AIDS Patient Care STDS (2001) 0.83

Oxidative sulfitolysis of human IgM. J Immunol (1971) 0.83

Finishing and detailing with a preadjusted appliance system. J Clin Orthod (1991) 0.82

Zinc and copper concentrations in hair of Iranian villagers. Am J Clin Nutr (1966) 0.82

Isolation and physico-chemical characterization of the "IgM-like" immunologlobulin from the stingray Dasyatis americana. J Immunol (1971) 0.81

Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR. J Virol Methods (2000) 0.81

Whooping-cough admissions to a paediatric hospital over ten years. The protective value of immunisation. Lancet (1977) 0.81

Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula vs those receiving long-chain-triglyceride-containing formula. J Am Diet Assoc (1997) 0.81

Viral dynamics in primary HIV-1 infection. Lancet (1993) 0.81